Highlights
- 1Acta neuropathologica communications · 2019
- 2Molecular and cellular biology · 2021
Publications
63 publications
Funding
11 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- KPPABLO 244527-01Developing novel MYC inhibitors for the treatment of pediatric brain tumorsPablove Foundation · 2025–2028No publications yet
- PIPCF 260558-01Targeting tumor cells dissemination in medulloblastomaPediatric Cancer Foundation · 2026–2027
- PIR01NS111997-05A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal IdentityNational Institute of Neurological Disorders and Stroke · 2020–2027
Completed grants (8)
- Sub-PIR41CA285172-01An IGF-1R targeted peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumorsNational Cancer Institute · 2023–2025 · via Nighthawk Biosciences, Inc.
- PIAMBF 220865-02Therapeutical reprogramming of DIPG cellsAndrew McDonough B+ Foundation · 2021–2024
- PIR03OD034499-01Deciphering the 3D genome of pediatric brain tumorsOffice of the Director, NIH · 2022–2024
- MPINACF 214311-01AO SNA Fellowship Award 2021-2023AO North America Charitable Foundation · 2021–2023
- KPMLF 192507-01Reprogramming Pediatric Brain Cancer CellsMatthew Larson Foundation for Pediatric Brain Tumors, The · 2019–2021
- PIR01NS093120-03Transcriptional Control of Glioma DevelopmentNational Institute of Neurological Disorders and Stroke · 2017–2020
- Sub-PIR21NS100182-01Role of Type I Interferon Signaling in Zika Virus Infection of the BrainNational Institute of Neurological Disorders and Stroke · 2017–2017 · via University of Pennsylvania
- PIR01CA134983-02Inhibitors of Hedgehog Signaling For Brain Cancer ChemotherapyNCI · 2009–2012 · via NIH RePORTER
Clinical research
1 study
Active
1 study- PIRadiogenomic Analysis of Pediatric GliomaWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2021)